This is supported by data from the cetuximab‐resistant CRC cell line KM12C harboring a NF1 truncating mutation with a similar allele frequency, in which restoration of the NF1 function reduced MEK and ERK phosphorylation as well as cell proliferation and increased cetuximab induced apoptosis [51]. The gene discussed is NF1; the disease is colorectal carcinoma.